Arthritis is a common disease that affects millions of people worldwide. This can be felt in the person's joints, skin and organs inside the body. Should the person feel anything wrong, it is advisable to go straight to the doctor.
Doctors have discovered that there are over 100 types of arthritis. Given the number, the doctor will not be able to know which one is affecting the person without an examination.
There are 2 common forms of arthritis. The first is rheumatoid arthritis which is considered a chronic disease. There is inflammation in the joints caused by cartilage damage. Anyone who has this will suffer long term joint damage that will lead to chronic pain and disability. Pain is usually felt when waking up in the morning and will gradually disappear during the day.
Rheumatoid arthritis is a problem that will not go away. This happens in three stages. The first is swelling. The second is the rapid division and growth of cells. The third is when these cells release enzymes that will eat the bone causing the joint to lose shape until the person will not be able to move it anymore.
Since this is systemic disease, it can spread and affect other organs in the body. The best way to prevent is from happening is detecting it early to prevent the person from being disabled.
This can be treated with proper medication and therapy. There many drugs available that the patient can use. Some drugs offer pain relief to reduce the inflammation. Others can just do one function.
The second is called osteoarthritis. This happens more often than rheumatoid arthritis but unlike the first, there is no inflammation present. The cartilage in the joint is damaged and will eventually degenerate. Pain will slightly be felt when the person gets up but this will hurt later on during the day.
Osteoarthritis can either be primary or secondary. When it is primary, it is often associated with age. It is similar to a car where the parts have to be replaced due to wear and tear. Doctors consider this to be normal as people grow older.
The secondary type is often associated with something else that has caused this to happen. Some of these factors are an injury that took place, heredity, obesity and bone density.
Osteoarthritis can be treated with medication, exercise, weight control, joint protection, physical and occupational therapy. This is done to relieve the pain and slow the progression of the disease.
Both of these are caused by different things. The common thing between these 2 types is that joint pain can happen anywhere in the body.
Given the many medications available to treat this disease, the patient has to be aware of the side effects of each before choosing which one to use. The doctor should explain these to the person in order to make the right decision.
Abbott wins new round of approval for Humira
Abbott wins new round of approval for Humira Chicago Sun-Times - Oct 05 2:33 AM
Abbott Laboratories landed U.S. regulatory approvals to market its rheumatoid arthritis drug Humira as a first-line treatment for the disease and to treat psoriatic arthritis, helping lift the Lake County-based company's weakened stock price.Save to My Web
Abbott's Humira Arthritis Drug Wins Expanded U.S. Approval Chicago Tribune - Oct 04 7:16 AM
Abbott Laboratories won U.S. regulatory approval to expand use of its Humira rheumatoid arthritis drug for early treatment of the joint-destroying disease.Save to My Web
Study Offers Clues To Origins Of Autoimmunity Science Daily - Oct 03 3:04 PM
Researchers at National Jewish Medical and Research Center have discovered a mechanism in the body that could lead to autoimmune diseases, such as lupus, rheumatoid arthritis, or diabetes. The research team, led by John Cambier, Ph.D., found that potentially harmful B cells circulating in the body are not permanently silenced as previously thought; they can awaken and regain the ability to launch Save to My Web
Rockville-Based Human Genome Sciences Inc. Buoyed By Drug Trial RedNova - Oct 06 8:34 PM
By Karen Buckelew Human Genome Sciences Inc. officials still are optimistic about a future late-stage human trial for the company's lupus drug candidate, though the compound recorded disappointing results in mid- stage trials.Save to My Web
<< Home